Understanding Methotrexate and Its Role
Methotrexate is a cornerstone medication, classified as a disease-modifying antirheumatic drug (DMARD), used in the management of autoimmune diseases like rheumatoid arthritis (RA), psoriasis, and some cancers [1.2.5, 1.3.1]. It works by suppressing the immune system to reduce inflammation and slow disease progression [1.5.3]. Given its effectiveness, the decision to discontinue treatment is significant and must be approached with a clear understanding of the potential consequences. Patients may consider stopping for various reasons, including achieving a state of remission, experiencing adverse side effects, or planning a pregnancy [1.2.1, 1.2.7]. However, this decision should never be made without consulting a rheumatologist [1.5.3].
The Primary Side Effect: Disease Flare-Ups
Clinical studies confirm that the most significant side effect of stopping methotrexate is not a traditional withdrawal syndrome but the risk of a disease flare-up [1.2.2, 1.3.3]. A flare is a period where the symptoms of the condition, which the medication was controlling, return and worsen [1.2.1].
Symptoms of a flare can include:
- Increased joint pain, stiffness, and swelling [1.2.1]
- Fatigue and fever [1.2.1]
- Return of skin lesions in psoriasis
- A general decline in well-being
The risk and severity of a flare can be influenced by several factors. One study showed that over 20% of RA patients who stopped methotrexate for four weeks experienced a flare, compared to only 7% of those who continued the medication [1.4.2]. The risk may also be higher for those who were on larger doses of the drug before stopping [1.2.1]. A study following patients who discontinued long-term methotrexate treatment found that 44.3% experienced a flare within six months [1.4.8]. The median time to the flare was approximately 99 days [1.4.8].
Tapering vs. Abrupt Stoppage
Whether to stop methotrexate abruptly or to taper the dose gradually is a key consideration discussed between a patient and their doctor.
- Abrupt Stoppage: Some sources state that stopping methotrexate abruptly is generally not a problem, aside from the potential for a disease flare [1.2.4, 1.5.1]. The medication itself does not cause physical dependence that leads to withdrawal symptoms like those associated with opioids or prednisone [1.2.2].
- Tapering: Many rheumatologists recommend gradually reducing the dose (tapering) rather than stopping it suddenly [1.5.2, 1.5.4]. Tapering allows the patient and doctor to monitor for early signs of a flare and potentially adjust the treatment plan before symptoms become severe [1.5.4]. This approach is often recommended for patients whose disease is well-controlled or in remission [1.2.1]. A doctor will consider factors like the duration of remission and any side effects the patient is experiencing before recommending a tapering schedule [1.2.1].
| Discontinuation Method | Potential Outcome | Best For... |
|---|---|---|
| Abrupt Stoppage | Higher risk of a sudden, more severe disease flare-up [1.5.4]. | Patients who need to stop immediately due to severe side effects or other urgent medical reasons, under a doctor's guidance [1.5.2]. |
| Tapering (Gradual Reduction) | May prevent or lessen the severity of a flare; allows for monitoring and intervention [1.5.4]. | Patients in stable remission or with well-controlled disease who are looking to reduce their medication load [1.2.1]. |
Managing Flares After Stopping Methotrexate
If a flare-up occurs after discontinuing methotrexate, the first step is to contact a healthcare provider. The most common medical response is to restart the previous treatment plan [1.2.1]. Studies have shown this to be effective; in one study, 75% of patients who restarted methotrexate after a flare were able to get back into remission [1.2.1].
Alongside medical intervention, several non-medication strategies can help manage symptoms during a flare:
- Pain and Swelling Relief: Using hot or cold packs on affected joints [1.2.1].
- Rest and Stress Management: Getting adequate sleep and reducing stress levels can help manage symptoms [1.2.1].
- Light Exercise: If approved by a doctor, gentle movement can prevent stiffness [1.2.1].
- Over-the-counter Medications: NSAIDs may be used to ease flare symptoms, but this should be discussed with a doctor [1.2.1].
The Role of Other Medications
The context of a patient's full treatment regimen is crucial. For patients taking methotrexate in combination with other drugs, particularly biologic DMARDs like etanercept or tofacitinib, the risk of a flare when stopping methotrexate may be reduced [1.2.1]. Research indicates that continuing the biologic drug while discontinuing methotrexate may not lead to a higher risk of flare-ups for some patients with stable RA [1.2.1]. This highlights the importance of a comprehensive treatment strategy managed by a rheumatologist.
Conclusion
While stopping methotrexate does not cause a classic withdrawal syndrome, the primary and most concerning side effect is the potential for a significant flare-up of the underlying autoimmune disease. The decision to stop or alter the dosage should never be undertaken without the direct supervision of a healthcare professional [1.5.3]. Tapering the dose is often preferred over abrupt cessation to minimize the risk of a severe flare and to allow for careful monitoring [1.5.4]. If a flare does occur, restarting the medication is often an effective strategy for regaining disease control [1.2.1].
For more information, you can visit the Johns Hopkins Arthritis Center.
